Mystic
Pharmaceuticals, Inc. today announced the availability of its
Javelin Sublingual™ drug delivery devices. Javelin Sublingual dispensers
utilized Mystic's VersiDoser® and VRx2™ platform technology, and are
offered in mono-dose and multi-dose configurations. Sublingual and
buccal delivery provides non-invasive, delivery of drugs, peptides,
proteins and enzymes through mucosal surfaces in the oral cavity. This
route avoids first pass metabolism, provides rapid systemic uptake into
the body and can be self-administered by the patient. Applications
include the delivery of therapeutics for pain, cardiovascular, allergy,
seizure, sedation, emesis, hormones, diabetes and vaccines.

Based on Mystic's VersiDoser® and VRx2™ delivery technology, Javelin
Sublingual dispensers provide precise dose delivery for liquid, powder
and reconstituted powder medications. All Javelin dispensers incorporate
patient-centric ergonomic design features such as side actuation, no
priming and contoured surfaces to facilitate ease of use, comfort and
safety for the patient.

Each Javelin dispenser is customized to the pharma manufacturer's Target (News - Alert)
Product Profile and technical specifications through Mystic's product
integration process. Utilizing the VersiDoser or VRx2 Delivery Platform
technology, Mystic can cost effectively provide an optimized commercial
product that delivers value for both the patient and the pharmaceutical
manufacturer. This approach eliminates the compromises that often arise
with commodity off the shelf dispensers.

Mystic will produce and fill Javelin Sublingual dispensers at its
Austin, Texas manufacturing facility and internationally through its
strategic manufacturing partners. For more information please visit http://www.mysticpharmaceuticals.com

About Mystic Pharmaceuticals, Inc.

Mystic Pharmaceuticals® is an integrated specialty pharmaceutical
manufacturer based in Austin, Texas. Mystic provides precision unit dose
delivery solutions for pharmaceuticals, biopharmaceuticals and biologics
for intranasal, nose-to-brain, ophthalmic, sublingual, and otic
applications. Mystic combines its novel delivery systems with
pharmaceuticals and biologics under development by Mystic and its
partners, to meet the expanding global market demand for healthcare
products that are safer, simpler to use and cost effective. For more
information please visit the Mystic website at: http://www.mysticpharmaceuticals.com